Autism Registry for French Guiana

Autism Spectrum Disorder Clinical Trial

— REGUYAUT  

Official title:

Autism Registry for French Guiana

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02903732
• Other study ID #: REGUYAUT
• Status: Recruiting
• Phase: N/A
• First received: September 6, 2016
• Last updated: September 13, 2016
• Start date: September 2015
• Est. completion date: December 2020

Study information

• Verified date: September 2016
• Source: Centre Hospitalier de Cayenne
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertésFrance: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The objective of the autism registry is to estimate the prevalence of autism in French Guiana in the cohort of children aged 8 years. Secondary objectives are to determine the prevalence of comorbidities, and to determine the theoretical and actual orientation of these children regarding care and education in a territory with significant structural deficits relative to mainland France. The outcomes of this registry will be to guide decision makers in their funding priorities to improve, screening, diagnosis, care and education for children on the autistic spectrum

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: December 2020
• Est. primary completion date: September 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 8 Years to 8 Years

Eligibility

Inclusion Criteria:

• children aged 8 years with a diagnosis of autism spectrum disorder

Exclusion Criteria:

• refusal to participate

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder

Intervention

Other:
• observational
registry

Locations

Country	Name	City	State
France	Centre Hospitalier de Cayenne	Cayenne	French Guiana

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier de Cayenne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	autism spectrum disorder	the number of 8 year old children with a diagnosis of autism spectrum disorder in a given year relative to the total population of children aged 8 years old in that given year	1 year (the year at age 8)	No